{"id":892568,"title":"An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics, CCDR 50(10) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T02:03:47.349000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/innovative-tool-prioritize-assessment-investigational-covid-19-therapeutics.html","snippet":"An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics Download this article as a PDF (196 KB) Published by: The Public Health Agency of Canada Issue: CCDR Volume 50-10, October 2024: COVID-19 after the pandemic Date published: October 2024 ISSN:…","rawSnapshotUrl":"/api/snapshots/raw/892568","browseUrl":"https://replay.healtharchive.ca/job-7/20260306020347/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/innovative-tool-prioritize-assessment-investigational-covid-19-therapeutics.html#ha_snapshot=892568","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}